QualityStocksNewsBreaks Archives - Page 2 of 1466

WednesdayDec 03, 2025 9:15 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug filing for NRX-101 to include use of the drug in combination with Transcranial Magnetic Stimulation for depression, including suicidal depression. The update follows evidence suggesting NRX-101 may significantly enhance TMS outcomes, with published studies showing more than two-fold improvements in symptom reduction and clinical response rates exceeding 80%. The Company noted NRX-101’s D-cycloserine component appears to augment neuroplasticity associated with TMS, while its low-dose lurasidone is intended to mitigate D-cycloserine’s known risk of low-grade hallucinations. NRx said it aims to validate the findings in a…

TuesdayDec 02, 2025 11:45 am

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Adopts Bitcoin Treasury Strategy With Initial Purchases Underway

Massimo Group (NASDAQ: MAMO) said its Board approved adding Bitcoin as part of a long-term treasury reserve strategy, with initial purchases already begun and holdings to be disclosed in upcoming SEC filings or via Form 8-K. The Company said the program will be funded primarily through operating cash flows, with the option to use market instruments, and will employ institutional-grade custody with multi-signature cold storage and audit-ready controls. Massimo expects Bitcoin to represent a single-digit percentage of total assets over five years, positioning it as a strategic reserve rather than an operating asset. CEO David Shan said the move reflects a…

TuesdayDec 02, 2025 11:19 am

QualityStocksNewsBreaks – GlobalTech Corp. (OTC: GLTK) Agrees to Acquire 51% of Moda in Pelle to Expand AI-Driven Retail and UK Market Reach

GlobalTech (OTC: GLTK), a U.S.-based technology holding company focused on AI, big data and emerging technologies, said it entered a definitive agreement to acquire a 51% interest in 123 Investments Limited d/b/a Moda in Pelle, a premium UK footwear brand with approximately $37 million in net revenue last year. The Company said the deal is expected to add a new revenue stream, strengthen its UK operational presence and enhance e-commerce capabilities through Thrivo AI integration, with closing expected within 30 days subject to customary conditions. CEO Dan Green said the acquisition aligns with GlobalTech’s value-creation strategy and will support…

TuesdayDec 02, 2025 11:01 am

QualityStocksNewsBreaks – Stewards Inc. (OTC: SWRD) Appoints Scott McGowan Chief Marketing Officer

Stewards (OTC: SWRD), a diversified financial company operating across private credit, real assets and digital finance, appointed Scott McGowan as chief marketing officer to lead integrated marketing and communications as the Company expands its operating segments and advances toward a planned Nasdaq Capital Market uplisting. McGowan, formerly director of investor relations at InvestorBrandNetwork and previously CEO of a strategic communications consultancy, brings more than 20 years of experience advising growth-stage companies on brand positioning, capital-markets strategy and stakeholder engagement. President Shaun Quin said McGowan will strengthen transparency and unify messaging as Stewards enters its next phase of growth. To view…

TuesdayDec 02, 2025 9:50 am

QualityStocksNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Adds Insurance and Employer-Benefits Leaders Chris Pulos and Jason Bishara to Board

HealthLynked (OTCQB: HLYK), an AI-driven global healthcare network focused on improving care coordination and reducing costs, appointed Chris G. Pulos of Marsh McLennan Agency and Jason Bishara of NSI Insurance Group to its Board. The Company said the additions bring decades of experience in employer benefits, payer strategy, insurance and risk management as HealthLynked expands collaborations with insurers, employer groups and healthcare organizations. Founder and CEO Dr. Michael Dent said their expertise will support national scaling of the HealthLynked Network and its AI platform, ARI, while strengthening governance ahead of a planned Nasdaq Capital Market listing. To view the full…

TuesdayDec 02, 2025 9:30 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) JV Sapu Nano Presents Data Showing Deciparticle Platform Supports Broad Hydrophobic Drug Formulation

Oncotelic Therapeutics (OTCQB: OTLC) said its 45%-owned joint venture, Sapu Nano, reported new data at the 2025 San Antonio Breast Cancer Symposium showing that its Deciparticle(TM) nanomedicine platform can consistently formulate structurally diverse hydrophobic therapeutics—including macrolide mTOR inhibitors, cyclic and linear peptides, ascomycin macrolactams and polyketides—into sub-20 nm nanoparticles suitable for IV delivery. The Company said the findings confirm Deciparticle as a versatile, cGMP-ready delivery platform backed by ISO-5 manufacturing capabilities that support rapid translation to Phase 1 supply. CEO Dr. Vuong Trieu said the results position Deciparticle as a modular engine for multiple oncology, immunology and peptide drug candidates,…

TuesdayDec 02, 2025 9:20 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said the FDA has received its Abbreviated New Drug Application for KETAFREE(TM), a preservative-free intravenous ketamine formulation, deeming the submission “substantially complete” and assigning a July 29, 2026 review goal date. CEO Jonathan Javitt said KETAFREE is designed to provide a single-patient, preservative-free alternative to current multidose ketamine vials that contain Benzethonium Chloride, a compound no longer recognized as safe by the FDA. The Company said KETAFREE aligns with MAHA initiatives to remove toxic substances from medicines and supports domestic supply-chain priorities, with potential 2026 approved drug sales if approved on schedule.…

TuesdayDec 02, 2025 9:10 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules Corporate Update Call for Dec. 2

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it will host a corporate update conference call on Dec. 2, 2025, at 9 a.m. Eastern to review recent clinical, regulatory and operational developments. To view the full press release, visit https://ibn.fm/9WZCK About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals, Inc. (www.nrxpharma.com), is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. The Company is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal…

MondayDec 01, 2025 1:53 pm

QualityStocksNewsBreaks – Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) CEO to Present at NobleCon21

Strawberry Fields REIT (NYSE AMERICAN: STRW) a self-administered REIT focused on healthcare-related properties, said Chairman and CEO Moishe Gubin will present at NobleCon21 on Dec. 3 at 4:30 p.m. Eastern at Florida Atlantic University’s Executive Education Complex. A high-definition webcast will be available on the NobleCon and Channelchek websites and will remain archived for 90 days. To view the full press release, visit https://ibn.fm/wOMyT About Strawberry Fields REIT Strawberry Fields REIT, Inc., is a self-administered real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing and certain other healthcare-related properties. The Company’s portfolio includes 142…

MondayDec 01, 2025 12:25 pm

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) Releases Updated Murdock Mountain Project Factsheet

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) published an updated Project Factsheet featuring new graphics that highlight the scale and consistency of the Murdock Mountain Upper Phosphatic Zone, with drilling intersecting the Meade Peak stratigraphy as predicted by the company’s geological model. Leadership said the refreshed visuals strengthen confidence in the project’s potential viability, and laboratory assay results will be released once received and validated. To view the full press release, visit https://ibn.fm/5PHTb About Nevada Organic Phosphate Inc. NOP is a junior exploration company with…

Site Search

Company Search

Category: QualityStocksNewsBreaks